Skip to main content
TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
34.58
-0.80 (-2.26%)
At close: Apr 28, 2026, 4:00 PM EDT
34.80
+0.22 (0.64%)
Pre-market: Apr 29, 2026, 7:22 AM EDT

TG Therapeutics Revenue

In the year 2025, TG Therapeutics had annual revenue of $616.29M with 87.32% growth. TG Therapeutics had revenue of $192.57M in the quarter ending December 31, 2025, with 78.00% growth.

Revenue (ttm)
$616.29M
Revenue Growth
+87.32%
P/S Ratio
8.29
Revenue / Employee
$1,544,579
Employees
399
Market Cap
5.11B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025616.29M287.28M87.32%
Dec 31, 2024329.00M95.34M40.80%
Dec 31, 2023233.66M230.88M8,290.02%
Dec 31, 20222.79M-3.90M-58.36%
Dec 31, 20216.69M6.54M4,300.66%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Apellis Pharmaceuticals 1.00B
Caris Life Sciences 812.03M
Corcept Therapeutics 761.41M
Amicus Therapeutics 634.21M
Ligand Pharmaceuticals 268.09M
Xenon Pharmaceuticals 7.50M
CG Oncology 4.04M
CRISPR Therapeutics AG 3.51M
Revenue Rankings

TGTX News

More News